La Beaute (LABI) investor relations material

Company overview and business model

• Operates a one-stop premium medical aesthetic platform integrating clinical services, medical-grade skincare, post-procedure repair products, and customized membership services.

• Monetizes through fee-for-service clinical treatments, product sales, and recurring membership subscriptions.

• Strategic focus on client-centric innovation, quality, and expansion across Asia and global markets, combining online and offline channels.

• Founded July 2, 2026, in California; 100% owned by Harmony Medical Group Limited prior to IPO.

Financial performance and metrics

• As of July 31, 2026, reported total assets, cash, revenues, gross profit, and expenses, but specific figures are not disclosed.

• No liabilities as of July 31, 2026; shareholders' equity is positive.

• Company recorded a net loss for the period ended July 31, 2026, resulting in an accumulated deficit.

• Current cash position may not be sufficient to support ongoing operations; going concern risk highlighted.

Use of proceeds and capital allocation

• Estimated net proceeds of approximately $50 million, assuming full subscription at $5.00 per share.

• Intended uses: strategic acquisitions/investments, marketing and promotional campaigns, global market expansion, and general working capital.

• Management retains broad discretion over allocation of proceeds; actual use may differ from current intentions.